((1aR,7aS,10aS,10bS,E)-1a-methyl-8-methylene-9-oxo-1a,2,3,6,7,7a,8,9,10a,10b-decahydrooxireno[2',3':9,10]cyclodeca[1,2-b]furan-5-yl)methyl 2-(5-fluoro-2,4-dioxo-3-propyl-3,4-dihydropyrimidin-1(2H)-yl)acetate

ID: ALA4470181

PubChem CID: 155534077

Max Phase: Preclinical

Molecular Formula: C24H29FN2O7

Molecular Weight: 476.50

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C=C1C(=O)O[C@H]2[C@H]1CC/C(COC(=O)Cn1cc(F)c(=O)n(CCC)c1=O)=C\CC[C@@]1(C)O[C@@H]21

Standard InChI:  InChI=1S/C24H29FN2O7/c1-4-10-27-21(29)17(25)11-26(23(27)31)12-18(28)32-13-15-6-5-9-24(3)20(34-24)19-16(8-7-15)14(2)22(30)33-19/h6,11,16,19-20H,2,4-5,7-10,12-13H2,1,3H3/b15-6+/t16-,19-,20-,24+/m0/s1

Standard InChI Key:  KFYNWLATSBTQIS-OPXDBTQMSA-N

Molfile:  

 
     RDKit          2D

 37 40  0  0  0  0  0  0  0  0999 V2000
   15.3991  -19.9747    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.8505  -19.2936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0335  -19.2422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6588  -21.2912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2866  -20.7636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9631  -20.8572    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.1607  -20.0613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9747  -20.0022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1701  -19.2098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4797  -18.7749    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4535  -17.9486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6574  -18.4194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7910  -17.4550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9929  -17.6672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1779  -17.5705    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8676  -18.0088    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.5920  -17.6306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6268  -16.8142    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.3545  -19.7007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7793  -18.4758    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   18.0801  -20.9590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7852  -19.9327    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   16.7165  -22.1064    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.4779  -20.4339    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   19.2817  -18.0689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0062  -17.6908    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.6934  -18.1318    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4155  -17.7570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4545  -16.9404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7651  -16.4999    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.0366  -16.8761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3468  -16.4380    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.1804  -16.5650    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.1036  -18.1979    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   20.8026  -15.6836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5283  -15.3079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5658  -14.4916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  1  3  1  0
  4  5  1  0
  5  8  1  0
  7  6  1  0
  6  4  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  2  7  1  0
 10 11  1  0
  3 12  1  0
 11 13  2  0
 12 14  1  0
 13 14  1  0
 11 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
  3 19  1  1
  2 20  1  1
  5 21  2  0
  8 22  1  6
  4 23  2  0
  7 24  1  1
 17 25  1  0
 25 26  1  0
 26 27  1  0
 26 31  1  0
 27 28  2  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  2  0
 29 33  2  0
 28 34  1  0
 30 35  1  0
 35 36  1  0
 36 37  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4470181

    ---

Associated Targets(Human)

Bel7402/5-FU (373 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bel-7402 (4577 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 476.50Molecular Weight (Monoisotopic): 476.1959AlogP: 1.86#Rotatable Bonds: 6
Polar Surface Area: 109.13Molecular Species: NEUTRALHBA: 9HBD:
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 2.60CX LogD: 2.60
Aromatic Rings: 1Heavy Atoms: 34QED Weighted: 0.27Np Likeness Score: 1.24

References

1. Ding Y, Li S, Ge W, Liu Z, Zhang X, Wang M, Chen T, Chen Y, Zhang Q..  (2019)  Design and synthesis of parthenolide and 5-fluorouracil conjugates as potential anticancer agents against drug resistant hepatocellular carcinoma.,  183  [PMID:31553932] [10.1016/j.ejmech.2019.111706]

Source